Evelo Biosciences, Inc., a clinical stage biotechnology company developing a novel platform of orally delivered medicines acting on the small intestinal axis, SINTAX, announced that on September 1, 2022, Marella Thorell commenced her services as Evelo’s Chief Financial Officer.
September 1, 2022
· 4 min read